Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Browse (a)

a b c d e f g h i j k l m n o p q r s t u v w x y z (0-9)

Abacavir, Dolutegravir, and Lamivudine

Abacavir, Lamivudine, and Zidovudine

Abaloparatide Injection

Abatacept Injection

AbobotulinumtoxinA Injection

Acetaminophen and Codeine

Acetaminophen, Butalbital, and Caffeine

Acetaminophen Injection

Acetaminophen Rectal

Acetylcysteine Oral Inhalation

Aclidinium Oral Inhalation

Acyclovir Buccal

Acyclovir Injection

Acyclovir Ophthalmic

Acyclovir Topical

Adalimumab Injection

Ado-trastuzumab Emtansine Injection

Aducanumab-avwa Injection

Afamitresgene Autoleucel Injection

Aflibercept Injection

Agalsidase beta Injection

Albiglutide Injection

Albuterol and Ipratropium Oral Inhalation

Albuterol Oral Inhalation

Alcaftadine Ophthalmic

Alemtuzumab Injection (Chronic Lymphocytic Leukemia)

Alemtuzumab Injection (Multiple Sclerosis)

Alirocumab Injection

Allopurinol Injection

Alprostadil Urogenital

Aluminum Hydroxide

Aluminum Hydroxide and Magnesium Hydroxide

Amifostine Injection

Amikacin Injection

Amikacin Oral Inhalation

Amiloride and Hydrochlorothiazide

Aminocaproic Acid

Aminocaproic Acid Injection

Aminolevulinic Acid Topical

Amisulpride Injection

Amivantamab-vmjw Injection

Amlodipine and Benazepril

Ammonium Lactate Topical

Amoxicillin and Clavulanic Acid

Amphotericin B Lipid Complex Injection

Amphotericin B Liposomal Injection

Ampicillin and Sulbactam Injection

Ampicillin Injection

Anifrolumab-fnia Injection

Anthrax Vaccine

Antipyrine-Benzocaine Otic

Apomorphine Injection

Apomorphine Sublingual

Apraclonidine Ophthalmic

Aprepitant/Fosaprepitant Injection

Arformoterol Oral Inhalation

Aripiprazole Injection

Arsenic Trioxide Injection

Artemether and Lumefantrine

Ascorbic Acid (Vitamin C)

Asenapine Transdermal Patch

Asparaginase Erwinia Chrysanthemi Injection

Asparaginase Erwinia Chrysanthemi (recombinant)-rywn Injection

Aspirin and Extended-Release Dipyridamole

Aspirin and Omeprazole

Aspirin, Butalbital, and Caffeine

Atazanavir and Cobicistat

Atezolizumab Injection

Atidarsagene Autotemcel Injection

Atovaquone and Proguanil

Atropine Ophthalmic

Avelumab Injection

Axatilimab-csfr Injection

Axicabtagene Ciloleucel Injection

Azacitidine Injection

Azelaic Acid Topical

Azelastine Nasal Spray

Azelastine Ophthalmic

Aztreonam Injection

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Houston Office
5115 Fannin Street, Museo Building, Suite 801
Houston, TX 77004
Telephone: 713-790-9125 or 713-790-0841
Fax: 713-790-9663
Sugar Land Office
16605 Southwest Freeway, Medical Office Building 3, Suite 360
Sugar Land, TX 77479
Telephone: 832-833-1705
Fax: 281-973-2228

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary